INK4d is a tumor suppressing protein and belongs to a family of cyclin D-dependent kinase inhibitors of CDK4 and CDK6, which play a key role in human cell cycle control. P19 comprises ten a-helices arranged sequentially in ®ve ankyrin repeats forming an elongated structure. This rather simple topology, combined with its physiological function, makes p19 an interesting model protein for folding studies. Urea-induced unfolding transitions monitored by far-UV CD and phenylalanine¯uor-escence coincide and suggest a two-state mechanism for equilibrium unfolding. Unfolding of p19 followed by 2D 1 H-
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INK4d is a tumor suppressing protein and belongs to a family of cyclin D-dependent kinase inhibitors of CDK4 and CDK6, which play a key role in human cell cycle control. P19 comprises ten a-helices arranged sequentially in ®ve ankyrin repeats forming an elongated structure. This rather simple topology, combined with its physiological function, makes p19 an interesting model protein for folding studies. Urea-induced unfolding transitions monitored by far-UV CD and phenylalanine¯uor-escence coincide and suggest a two-state mechanism for equilibrium unfolding. Unfolding of p19 followed by 2D 1 H-15 N HSQC spectra revealed a third species at moderate urea concentrations with a maximum population of about 30 % near 3.2 M urea. It shows poor chemical shift dispersion, but cross-peaks emerge for some residues that are distinct from the native or unfolded state. This equilibrium intermediate either arises only at high protein concentrations (as in the NMR experiment) or has similar optical properties to the unfolded state. Stoppedow far-UV CD experiments at various urea concentrations revealed that a-helical structure is formed in three phases, of which only the fastest phase (10 s À1 ) depends upon the urea concentration. The kinetic of the slowest phase (0.017 s À1 ) can be resolved by 1D real-time NMR and accelerated by cyclophilin. It is limited in rate by prolyl isomerization, and native-like ordered structure cannot form prior to this isomerization. The two fast phases lead to 83 % native protein within the dead time of the NMR experiment. In contrast to p16 INK4a , which exhibits only a marginal stability and high unfolding rates, p19 shows the expected stability for a protein of this size with a clear kinetic barrier between the unfolded and folded state. Therefore, p19 might complement the function of less stable INK4 inhibitors in cell cycle control under unfavorable conditions.
Introduction
Cyclin-dependent kinases (CDKs) are important in controlling the eukaryotic cell cycle. 1 Two families of CDK inhibitors block the progression from the G1 to the S phase by negatively regulating the kinase activity of different CDKs: the Cip/Kip and INK4 families. 1 ± 4 The INK4 family comprises p16
INK4a (p16), p15 INK4b (p15), p18
INK4c
(p18), and p19 INK4d (p19), which speci®cally bind and inhibit CDK4 and CDK6. Both kinases become activated by cyclin D and phosphorylate the retinoblastoma gene product (pRb), which activates genes associated with S phase progression via the transcription factor E2F. 5 Alterations in at least one of the main regulators of the G1 to S transition were found in the vast majority of human cancer cases, such as familial melanoma. 6, 7 Mutations in members of the INK4 family are particularly wide-spread, and up to 80 % of certain tumor types show alterations in p16. 8 The structure of all members of the INK4 family comprises four or ®ve ankyrin repeats as a common motif 9 ± 12 and all of them bind with similar af®nity to CDK4 or CDK6. Despite these shared properties, they can differ in post-translational modi®cations or in the expression level in different cell types or differentiation states (see references in 13 ).
Here we investigated the stability and folding properties of human CDK inhibitor p19. It is the only member of the INK4 family that is particularly phosphorylated in vivo 13 and oncogenic mutations were found mainly in human bladder cancer.
14 p19 knock-out mice are fertile but have deformed testicles. 15 p19 represents a promising model to study elementary protein folding reactions. Human p19 contains 165 amino acid residues and has a remarkable structure comprising ®ve ankyrin repeats ( Figure 1 ) as shown by several NMR and crystallographic studies of the free and complexed protein. 9, 16, 17 The ten helices are sequentially arranged. Therefore, the native 3D structure can form in the absence of extensive long range interactions that are required for the folding of highly intertwined proteins with a complex topology. 18 Furthermore, p19 contains no cystine, which can signi®cantly retard folding due to very slow isomerization reactions. Oxidized cystine residues can induce arti®cial structural constraints in the unfolded state that are not present during the in vivo folding reaction.
Another remarkable property of p19 is that it contains no tryptophan and no tyrosine residues. Therefore, optical methods for studying the stability and kinetics of folding are limited to amide circular dichroism (CD), which probes the formation of secondary structure elements. To follow the formation of tertiary structure and its stability against urea, we used the intrinsic¯uorescence of the four phenylalanine residues, which can be well studied in the absence of Trp and Tyr and which have rarely been used for protein folding studies. 1D real-time NMR and 2D 1 H-15 N NMR spectroscopy were particularly useful to follow the folding reaction at many speci®c positions in the polypeptide chain.
By comparing urea transitions monitored by different spectroscopic probes, we found that under equilibrium conditions a third conformation (in addition to the unfolded and folded states) becomes detectable by NMR spectroscopy at moderate urea concentrations with a maximum population of 32 % at 3.25 M urea. All observed transitions are cooperative folding reactions as judged by following NMR spin labels at many sites on the protein. Stopped-¯ow CD experiments revealed that the native a-helical backbone conformation forms in three phases. The slowest phase, with an amplitude of about 7 %, is limited in rate by a prolyl isomerization. A real-time NMR experiment showed that protein molecules contributing to this very slow phase are mainly unstructured before the rate-limiting step. The two fast phases lead to molecules with native tertiary structure within the dead time of this NMR experiment.
Results

Equilibrium stability of p19
Three probes were used to monitor the unfolding of CDK inhibitor p19 under equilibrium conditions: CD spectroscopy in the far-UV region (far-UV CD), intrinsic phenylalanine¯uorescence, and 2D 1 H-15 N-NMR spectroscopy. p19 folds reversibly under all presented conditions. Figure 2 (a) depicts the far-UV CD spectrum of p19 at 25 C, pH 7.5. The spectrum shows distinct minima at 207 nm and 222 nm characteristic of a-helical backbone conformation. Denaturation of the protein with high concentrations of urea results in a loss of the minimum at 222 nm, which was used to monitor unfolding transitions. The respective transition is cooperative with a midpoint of 2.9 M urea at 15 C ( Figure 3) . A thermal unfolding transition observed by far-UV CD at 222 nm is also reversible (data not shown), and the baseline for native protein extends to about 40 C. In retrospect, this con®rms that all structural characterizations of human p19 with ). The assembly of ®ve ankyrin repeats, comprising 33 amino acid residues each, form a non-globular elongated structure with a sequential arrangement of all ten helices. The four phenylalanine residues are indicated in a ball-and-stick representation.
NMR spectroscopy at 27 C in solution have been performed with fully native protein. 9, 19, 20 The midpoint of the temperature transition is at 51.9 C.
Phenylalanine fluorescence monitors the tertiary structure
To probe for changes in the tertiary structure, we used the intrinsic phenylalanine¯uorescence, which was possible because p19 contains no Trp or Tyr residues. Figure 1 depicts the well dispersed positions of Phe41, Phe51, Phe86, and Phe125 within the 3D structure of p19. Phe¯uorescence is two orders of magnitude less sensitive than Trp uorescence because of the low quantum yield and extinction coef®cient of Phe. 21 However, in the absence of Trp and Tyr residues, the Phe¯uor-escence is sensitive enough to follow unfolding transitions. The decrease in Phe¯uorescence upon unfolding in 6 M urea is illustrated in Figure 2 C. Figure 4 illustrates the loss of the chemical shift dispersion of p19 upon unfolding due to missing tertiary interactions in the unfolded state. For a number of residues (labeled in Figure 4 (a)), entire transition curves are shown in Figure 5 . Their cross-peaks are undisturbed by strong overlap with other resonances at all urea concentrations. This is not the case for all resolved resonances in Figure 4 since the chemical shifts of both the native and unfolded states depend on the urea concentration, which can cause cross-peaks to overlap at medium urea concentrations. All analyzed residues of the native state show urea unfolding transitions with midpoints around 2.9 M urea and very similar cooperativities. The resonances of the unfolded state also followed very similar urea transitions, but their midpoints are shifted to around 3.6 M urea. Therefore, plotting the native and unfolded fractions on one graph ( Figure 6 ) shows that the two curves do not intersect at 0.5 fractional change, thus violating a basic requirement for a two-state N U unfolding reaction. Consequently, a third species has to be taken into account at medium urea concentrations. Its population can be calculated by subtracting the native and unfolded popu- 
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INK4d lations from unity and has a maximum value of 0.32 at 3.25 M urea (gray curve in Figure 6 ).
By close inspection of the HSQC spectra we could identify eight additional cross-peaks that arise at medium urea concentrations, but belong to neither the native nor the unfolded state. A representative example is indicated in Figure 7 by a black frame. Its intensity increases from 2.25 M urea to 3.25 M urea, before decreasing again at higher urea concentrations. In comparison, the cross-peak intensity of A17 (representative of the native state) decreases and the intensity of crosspeaks of the unfolded state (labeled with U) increase with increasing urea concentrations. The intensities of the indicated cross-peak of the intermediate state in Figure 7 are included in Figure 6 as gray triangles. They follow the calculated gray curve very well.
Folding kinetics
We derived un-and refolding kinetics of p19 at various urea concentrations by a stopped-¯ow far-UV CD study at 225 nm and 15 C (Figure 8 ). All unfolding experiments of native p19 at urea concentrations between 2.8 M and 6.0 M showed single exponential increases of the ellipticity. At high urea concentrations, the unfolding rate is about 0.3 s
À1
. Refolding of p19 from 6 M urea to different low urea concentrations between 0.5 M and 1.8 M urea revealed two phases. The rate constant of the fastest phase (4 s À1 at 0.6 M urea) decreases linearly with increasing urea concentrations, whereas the slower phase (0.25 s À1 at 0.6 M urea) is almost urea-independent. A further urea-independent very slow refolding phase (0.01 s À1 ) could be resolved by manual mixing experiments. The relative amplitudes of these three phases are not affected by the urea concentration and are 79 % (fast phase), 14 % (slow phase) and 7 % (very slow phase).
Very slow folding events are often caused by isomerizations of prolyl peptide bonds. 22 Therefore, we repeated the refolding experiment from 6 M urea to 0.5 M urea in the presence of 3 mM cytosolic E. coli cyclophilin 18, which retains a prolyl isomerization activity of about 70 % at this urea concentration (R. Maier and F.X. Schmid, unpublished results). At 15 C, the very slow phase could be accelerated by a factor of 3, indicating that a prolyl isomerization might be causing this very slow folding event. It should be noted that all prolyl peptide bonds were found in a trans conformation in the crystal structure of p19.
To derive higher resolution time-resolved data during the refolding of p19, a 1D real-time NMR experiment was performed. Rapid mixing of 50 ml unfolded protein in 6 M urea with 450 ml refolding buffer inside the NMR spectrometer (as described before 23 ) initiates the refolding process, which was followed by a series of 100 1D spectra. Refolding at low urea concentrations caused partial aggregation under NMR conditions (0.7 mM ®nal protein concentration). To avoid aggregation, we used 2 M urea and 15 C as the ®nal refolding condition, which is close to the end of the native baseline of the unfolding transition. The dead time of real- N NMR correlation spectra (HSQC) of (a) native and (b) urea-unfolded p19 at 15 C, pH 7.5. Labeled cross-peaks indicate well-resolved residues, for which the entire urea transition is given in Figure 5 . The black frame speci®es the expanded region shown in Figure 7. time NMR spectroscopy is about one second, 24 and therefore, the fast folding reactions detected with stopped-¯ow CD spectroscopy (Figure 8) could not be followed. The 1D spectrum recorded during the ®rst ten seconds is already dominated by resonances of native p19.
A detailed analysis of the real-time NMR data shows that all 1D spectra can be represented by a linear combination of two components, depicted in Figure 9 (a) and (b). Figure 9(a) illustrates the spectrum of the ®nal, folded state in 2 M urea. The spectrum closely resembles the 1D spectrum of p19 in 0 M urea, which was never unfolded. The wide dispersion of the amide protons ranges from 6.5 ppm to 11.3 ppm. In contrast, the second component shows a 1D spectrum with very poor dispersion (Figure 9(b) ). This kind of spectrum resembles a mainly unfolded protein without substantial tertiary interactions.
To is shown in Figure 10 (b) and contributes about 17 % to the ®rst spectrum recorded after initiation of the refolding reaction. This refolding rate found by time-resolved NMR spectroscopy corresponds to the very slow phase derived from the far-UV CD kinetics (rhombus in Figure 8 ).
Discussion Spectroscopic properties of the folding intermediate
Following the urea-induced unfolding of CDKinhibitor p19 by CD, phenylalanine¯uorescence, and NMR spectroscopy revealed an equilibrium and intermediate (I). All unfolding transitions based on the NMR cross-peak intensities of the native state have virtually identical cooperativities and midpoints around 2.9 M urea. The resonances of the unfolded state that could be resolved follow identical transitions but the midpoint is shifted to 3.6 M urea. Thus, unfolding at equilibrium seems to be a concerted event for all sites of p19. This is noteworthy because p19 has an elongated nonglobular structure where the a-helices are arranged sequentially without extensive tertiary interactions. In contrast, the molten globule state of a-lactalbumin with almost native a-helicity but without a de®ned tertiary structure shows a non-cooperative unfolding transition. 26 The deviation of the NMR data from a two-state model might have originated from protein aggregation at intermediate urea concentrations, which would reduce the intensities of the NMR resonances. We can exclude such an aggregation by analyzing the cross-peak intensities of C-terminal L166, which has the same amide chemical shifts in the folded and unfolded state. It has a constant intensity at all urea concentrations, indicating that the concentration of soluble protein did not change.
The most compelling evidence for a third species at moderate urea concentrations comes from individual cross-peaks in the HSQC spectra that do not belong to U or N. We found at least eight wellresolved cross-peaks of the equilibrium intermediate, all following the same intensity pro®le with a maximum near 3.2 M urea as indicated in Figures 6  and 7 . The chemical shift dispersion of the reson- Figure 6 . Normalized populations of (*) native, ( ) intermediate, and (*) unfolded p19 derived from the urea-induced unfolding transition monitored by 2D NMR spectroscopy. The gray curve represents the missing fraction that needs to be added to the native and unfolded fraction to reach unity. Gray triangles correspond to the experimentally determined intensities of the well-resolved cross-peak of the equilibrium intermediate from Figure 7 scaled to 0.32 at 3.25 M urea. An alternative explanation would be the difference in protein concentration. In the NMR experiment it is 70 to 700 times higher than in the optical experiments. An intermediate state populated only at high protein concentrations implies a higher oligomeric state of I compared to U and N (found for example in bovine growth hormone 27 ). We can exclude oligomers larger than trimers, because several sharp NMR resonances of I are detectable in a conventional HSQC experiment.
Deviation of NMR-detected urea transitions from CD or¯uorescence data have also been observed for other proteins. For ferricytochrome c and the rat intestinal fatty acid binding protein, an unfolding intermediate that was silent in the apparently two-state CD-and¯uorescence-detected transitions was revealed by NMR spectroscopy. 28, 29 Unfolding transitions of apo¯avodoxin from Azotobacter vinelandii followed by far-UV CD and¯uorescence spectroscopy do not coincide, but ®t a model where a molten globule-like intermediate is populated under equilibrium conditions. 30 Interestingly, in this case the unfolding transitions monitored by 1 H-15 N NMR spectroscopy for 21 backbone positions all coincide with the¯uor-escence data.
NMR spectroscopy and optical data do not always differ. For example, folding experiments monitored with different methods including NMR spectroscopy of the histidine-containing phosphocarrier protein HPr from Escherichia coli revealed coinciding two-state transitions for all probes. 31 Three refolding phases dominate the formation of native p19
The sequential arrangement of the secondary structure elements in p19 might suggest a refolding scenario where the formation of individual a-helices is followed by formation of single ankyrin repeats and the assembly of the repeats is the ®nal folding step. Indeed, under strong native 
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INK4d conditions we observe three refolding phases by following the formation of helical structure in the time-resolved far-UV CD experiments.
Compared to optical methods, the 1D real-time NMR experiments provide a closer insight into the structural rearrangements during the refolding reaction. Comparable refolding rates for several proteins have been determined by¯uorescence, near-UV CD, and real-time NMR spectroscopy.
23,32 ± 36 For p19, only the slowest phase could be resolved with the NMR technique. This rate coincides with the rate of the slowest phase derived by far-UV CD spectroscopy. This shows that despite the differences in the equilibrium unfolding of p19 monitored by optical and NMR spectroscopy, the very slow refolding rate is concentration-independent. Secondly, the coinciding rates demonstrate that the secondary and tertiary structure form cooperatively during the very slow phase, in contrast to proteins such as apo alactalbumin. 23 The folded molecules appear at the same rate as the unfolded molecules disappear. This shows that the very slow folding protein moiety starts from a highly unstructured state, possibly with a mixture of prolyl conformations. This contrasts with the refolding reaction of ribonuclease T 1 , which is also retarded by a cis/trans prolyl isomerization. 25 For this protein, the very slow refolding phase (83 % of the molecules) starts from a highly structured folding intermediate. We cannot distinguish at present whether the very slow folding but unstructured state of p19 originates from a heterogeneity of the unfolded state, from the equilibrium intermediate that is populated to some extent at 2 M urea, or from an unstructured kinetic intermediate.
The two fast phases observed by stopped-¯ow far-UV CD experiments could not be resolved by the real-time NMR experiment. The ®rst NMR spectrum reveals that the two fast phases result in a burst of 83 % native p19 during the dead time of the NMR experiment. Taking together the results from the fast and very slow folding phases, we can conclude that these reactions occur in parallel, rather than sequentially.
Comparison with p16
Recently, Tang et al. characterized the stability and folding of p16, another member of the INK4 family.
37 p16 and p19 show a sequence identity of 40 %, thus a comparison of these structurally and functionally related proteins 38 should help us to understand similarities and differences in stability and folding mechanisms within this protein family.
Both p19 and p16 show apparent two-state unfolding behavior when folding is probed by optical spectroscopy. The midpoints of the ureainduced unfolding of p19 and p16 are 2.9 M urea (15 C) and 1.9 M urea (25 C), respectively. The small difference in temperature can probably not explain the enhanced stability of p19. Therefore, we suggest that the ®fth ankyrin repeat in p19 increases the thermodynamic stability in comparison to p16, which contains only four ankyrin repeats. The ®fth repeat contributes an additional hydrophobic core of ®ve leucine residues (109, 132, 145, 154, 158), two valine residues (115, 123), Ile111 and His112. Six of these hydrophobic residues are contributed by the forth ankyrin repeat in p19. Positions H112, V115, and L132 are occupied by polar amino acids in p16 (D112, E115, and R132) to avoid an extended solvent-exposed hydrophobic surface at the C terminus of p16. It is interesting to note that residues of the ®fth ankyrin repeat show the highest helix propensity in an AGADIR investigation of the p19 sequence. 39, 40 This ®nding further supports the importance of helices 9 and 10 for the formation of native p19. A dissection study of p16 showed that the minimum autonomous folding unit of p16 comprises only the C-terminal third and fourth ankyrin repeat, whereas peptides representing single ankyrin repeats are unstructured. 41 Despite these differences in structure and stability, p16 and p19 depict remarkable similarities in their refolding kinetics. Both proteins show three refolding phases at low urea concentrations and one unfolding phase. Only the fastest phase depends signi®cantly on the urea concentration. À`r oll-over'' of this fastest phase under strong native conditions as found for p16 is not obvious for p19. This deviation from linearity is usually found for proteins that form an intermediate with reduced stability during the refolding process. It should be noted that the kinetic data of p16 (which contains two tryptophan residues) were derived by stopped-¯ow¯uorescence spectroscopy, which has shorter dead times and a signi®cantly better signal/noise ratio than stopped-¯ow CD spectroscopy. Therefore, we may have missed a roll-over at very low urea concentrations.
The second, much slower phase during the refolding of p16 was only detectable by¯uor-escence, but not by stopped-¯ow CD, which led to the conclusion that a possible folding intermediate populated during refolding of p16 is highly unstructured. In the case of p19, all three phases are accompanied by a change in the far-UV CD signal at 225 nm. The second refolding phase is revealed for both proteins at urea concentrations below 1.5 M urea and is essentially independent of the urea concentration.
The third, very slow phase of both proteins is also urea-independent and accelerated by a prolyl isomerase. P16 contains ten and p19 six trans prolyl peptide bonds. Tang et al. showed for p16 by a double-jump experiment that heterogeneity in the isomerization state of these prolyl peptide bonds in the unfolded state is the most likely reason for this very slow phase. 37 A direct comparison of the amplitudes of the three phases between p16 and p19 is not possible because different probes were used and each phase has a distinct contribution to the¯uorescence, CD, or NMR spectrum. Both proteins share a common trait in that the observed amplitudes account for the entire¯uorescence or ellipticity change as predicted by the respective equilibrium studies. Therefore, very fast folding events during the dead time of the stopped-¯ow experiments can be ruled out.
Tang et al. suggested that proteins of the INK4 family in general might need a thermodynamic and kinetic instability for their regulatory function.
37 p19 shows no signi®cant deviation in stability from other proteins of this size with reasonable kinetic barriers and comparable inhibitor activity to p16. The increased thermodynamic and kinetic stability of p19 compared to p16 can be advantageous under less favorable cell conditions. For example, at increased temperatures, the less stable p16 is in a faster exchange with its unfolded state compared to p19, and is therefore subject to degradation. Under such conditions, p19 might complement the function of the less stable INK4 inhibitors in cell cycle control.
Materials and Methods
Urea (ultrapure) was from ICN (Cleveland, USA) and all other chemicals from Merck (Darmstadt, Germany). All experiments except the thermal unfolding transition were performed at 15 C and 20 mM Na-phosphate (pH 7.5). The concentration of urea was determined by the refraction of the solution.
42 p19 was prepared as described. 19 Equilibrium CD spectra were recorded with a JASCO J600A spectropolarimeter (0.1 cm cell length, 10 mM protein concentration, and 1 nm bandwidth) and corrected for the contributions of the buffer. The thermal unfolding transitions with 1 mM protein samples were monitored by the increase of the CD signal at 222 nm at 60 deg. C/hour heating rates and evaluated using non-linear least squares ®t as described by Mayr et al. 43 Far-UV CD urea-induced unfolding transitions of p19 were monitored at 222 nm for 1.5 mM protein solutions with varying urea concentration and two hours incubation time to reach equilibrium conditions. Urea transitions monitored by the intrinsic phenylalanine¯uorescence were recorded with a Hitachi F-4010 uorescence spectrometer with an excitation wavelength of 258 nm (5 nm bandwidth), an emission wavelength at 284 nm (20 nm bandwidth), and a 4 mM protein sample.
A urea unfolding transition experiment was followed by 2D Stopped-¯ow far-UV CD kinetic experiments were monitored at 225 nm with a Bio-Logic (Claix, France) PMS 400 detection system connected to a Bio-Logic SFM3 mixer with a cell path length of 1.5 mm. The unor refolding of p19 was initiated by a tenfold dilution of a 100 mM protein solution either in 0 M or 6.0 M urea, respectively, with buffers containing various amounts of urea. Typically, four kinetic traces per urea concentration were averaged and a sum of exponential functions was ®tted to the data using the program GraFit (Erithacus, Surrey, UK). The very slow refolding phase was determined by manual mixing (3 mM protein in 0.5 M urea ®nal conditions), since the baseline of the stopped-¯ow CD spectrometer was only stable for 20 seconds.
For the real-time NMR experiments, a second protein preparation was used. A comparison of the sequence with the ®rst preparation showed that the ®rst preparation had a single point mutation at position 32 from Leu to Met. All studies except the real-time NMR and the intrinsic phenylalanine¯uorescence experiments were performed with protein from the ®rst preparation.
Urea and temperature-induced transitions and far-UV CD refolding kinetics using manual mixing show identical results for protein from both preparations, indicating that this single mutation does not affect the stability and folding properties of p19. For the time-resolved NMR experiment, 50 ml of unfolded p19 in 6 M urea was rapidly diluted with 450 ml refolding buffer containing 2.22 M urea and 10 % 2 H 2 O with an experimental setup described by van Nuland et al. 24 The water resonance was suppressed by WATERGATE 44 and the urea resonance by an off-resonant presaturation during the relaxation delay of one second. 100 1D NMR spectra were recorded during the refolding experiment at 600 MHz with 9615 Hz spectral width and four scans per spectrum.
